Clinical Trials Browser

OTHER × eltrombopag × Clear all

NCT03948529 2025-09-30

REGALIA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia

NCT06630221 2025-07-03

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT04485416 2025-04-10

CCPO011

Phase 1 Suspended

Other solid neoplasm

Solid Tumor, Childhood

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Phase 4 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Phase 2 Recruiting

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT03603795 2024-10-29

EPAG2015

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05961410 2024-10-18

EPBSCH

Phase 2 Recruiting

Lymphoma

NCT02446145 2024-03-29

DELTA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

Phase 2/3 Completed

21 enrolled 10 charts

Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

23 enrolled 9 charts

Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Terminated

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT02071901 2021-12-01

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Phase 2 Unknown

31 enrolled 14 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01113502 2021-08-05

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

44 enrolled 16 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02323178 2021-04-20

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Phase 1/2 Completed

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

NCT01656252 2020-11-03

PrE0901

Phase 1/2 Terminated

15 enrolled 5 charts

Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT02010645 2020-01-02

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

6 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Chronic

NCT01286675 2019-03-01

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

Phase EARLY_PHASE1 Completed

Multiple Myeloma

NCT03701217 2018-10-09

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2/3 Unknown

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01610180 2018-07-16

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Purpura, Thrombocytopenic, Idiopathic

NCT02093325 2017-10-24

A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Phase 3 Unknown

Classical hematology

Thrombocytopenia

NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Phase 2 Terminated

1 enrolled 1 chart

Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

NCT01488565 2016-02-15

Aza-E

Phase 2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01500538 2016-02-15

VEIL

Phase 2 Terminated

Classical hematologyLymphoid

Lymphoma, Lymphoma, Follicular, Thrombocytopenia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01757145 2015-06-19

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Phase 2 Unknown

Other hematologic neoplasm

Bone Marrow Failure Disorders, Hematologic Neoplasms

NCT01397149 2015-05-28

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Phase 1/2 Terminated

Classical hematologyLymphoidOther hematologic neoplasm

Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Phase 1 Terminated

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue